Outpatient Surgery Magazine

ORX Awards and the Winners Are ... - September 2014 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/378604

Contents of this Issue

Navigation

Page 130 of 170

1 3 1 S E P T E M B E R 2 0 1 4 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E Omeros Corporation Omidria (phenylephrine and ketorolac injection) 1% / 0.3% omeros.com Pricing: not disclosed FYI: Scheduled for a U.S. product launch in the fourth quarter of 2014, the Omeros Corporation's recently FDA-approved drug Omidria offers to solve 2 cataract surgery complications at once: intraoperative pupil constriction and post-operative pain. A mydriatic (pupil-dilating) agent maintains the opening's size consistently, while the anti-inflam- matory ketorolac eases recovery and reduces the need to administer pre-operative NSAIDs. Added to the ocular irrigation solution in use during surgery, this proprietary compound facilitates predictable pro- cedures without the need to change surgeons' techniques or routines, says the company. O P H T H A L M O L O G Y

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - ORX Awards and the Winners Are ... - September 2014 - Subscribe to Outpatient Surgery Magazine